Sun Pharma Advanced Research Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 59.75 | -100% | -29.86 | -100% |
| P/S |
|
161.86 | 9.35 | 1631.14% |
|
|
| P/BV |
|
97.24 | 6.66 | 1358.97% |
|
|
| P/FCF |
|
-13.75 | -112.82 | -87.81% |
|
|
| Ev/Ebitda |
|
-32.92 | 141.69 | -123.23% |
|
|
| Ev/S |
|
162.6 | 9.62 | 1590.15% |
|
|
| Ev/FCF |
|
-26.96 | -85.06 | -68.31% |
|
|
| E/P |
|
-0.0618 | 0.1135 | -154.47% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-493.94 | 5.7 | -8766.84% | -251.72 | +96.22% |
| ROE |
|
-121.28 | 10.72 | -1230.88% |
|
|
| ROA |
|
-57.57 | 7.64 | -853.78% |
|
|
| ROIC |
|
0 | 15.91 | -100% |
|
|
| ROS |
|
-512.56 | -4.5 | 11288.93% |
|
|
| ROCE |
|
-306.67 | 13.31 | -2403.57% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1639 | 121.74 | -100.13% | -0.5311 | -69.14% |
| Nеt Debt/Ebitda |
|
-0.1496 | 121.47 | -100.12% |
|
|
| Debt/Ratio |
|
0.1187 | 0.145 | -18.14% |
|
|
| Debt/Equity |
|
0.57 | 2.02 | -71.79% |
|
|
| Debt/Net Income |
|
-0.1579 | 5.06 | -103.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 9.47 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.9146 | -100% | ||
| DSI |
|
0 | 0.8409 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9415 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 15.05 | -100% |
|
|
| Average percentage for payments |
|
0 | 24.67 | -100% |
|
|
| Difference from average difference in sector |
|
-9.47 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-1.65 | 386.27 | -100.43% | ||
| Growth impulse Ebitda in 5 years |
|
21.53 | 401.44 | -94.64% | ||
| Growth impulse Net Income in 5 years |
|
23.95 | 650.71 | -96.32% | ||
| Growth impulse FCF in 5 years |
|
72.06 | 803.01 | -91.03% | ||
| Growth impulse EPS in 5 years |
|
2.33 | 179.54 | -98.7% |
IP Score
3.04/10
